Loading…
Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors
Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of...
Saved in:
Published in: | Progress in transplantation (Aliso Viejo, Calif.) Calif.), 2011-09, Vol.21 (3), p.236-247 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13 |
---|---|
cites | cdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13 |
container_end_page | 247 |
container_issue | 3 |
container_start_page | 236 |
container_title | Progress in transplantation (Aliso Viejo, Calif.) |
container_volume | 21 |
creator | Shafer, Teresa J. Schkade, David Schkade, Lawrence Geier, Steven S. Orlowski, Jeffrey P. Klintmalm, Goran |
description | Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted. |
doi_str_mv | 10.1177/152692481102100309 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_896829840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_152692481102100309</sage_id><sourcerecordid>896829840</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</originalsourceid><addsrcrecordid>eNp9kctuEzEUhi0EomngBVhUFhtWQ308nozdXZXSixRRhAILNiPbY0duZ-xgj5H6DH3pOk0BqUgsjqwjf-c_lx-hd0A-ArTtMTR0ISjjAIQCITURL9CMwoJVi5bwl2i2A6odcYAOU7ohhLaMk9fogIJoW86bGbr_YWLAX126xeswmCi9NngZ0pTwyv0y6QSvQko4WLwuf2k7SD9JNRh8HTclx2fZ4CngyzxKj6_GMfvQG-u0M17f4e8u5oQ_Zz0Yp_Gpdj1emzQ5v9kpfgmT8ZOTAz4LPsT0Br2yckjm7dM7R9_OP62Xl9Xq-uJqebqqNAUmKkZkw2rCSM1ZTcsqqoQlFlplOeubRiumGhCNlr0FDgp6wjSntaqVEhbqOfqw193G8DOXebrRJW2GspsJOXVcLDgVvDSYo_fPyJuQoy_DFejxmFQUiO4hHcuporHdNrpRxrsOSLczqvvXqFJ09KSc1Wj6PyW_nSnA8R5IcmP-tv2P5APqApqa</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>892748029</pqid></control><display><type>article</type><title>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</title><source>Sage Journals Online</source><creator>Shafer, Teresa J. ; Schkade, David ; Schkade, Lawrence ; Geier, Steven S. ; Orlowski, Jeffrey P. ; Klintmalm, Goran</creator><creatorcontrib>Shafer, Teresa J. ; Schkade, David ; Schkade, Lawrence ; Geier, Steven S. ; Orlowski, Jeffrey P. ; Klintmalm, Goran</creatorcontrib><description>Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted.</description><identifier>ISSN: 1526-9248</identifier><identifier>EISSN: 2164-6708</identifier><identifier>DOI: 10.1177/152692481102100309</identifier><identifier>PMID: 21977885</identifier><identifier>CODEN: PTRRBT</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>AIDS Serodiagnosis ; Cost-Benefit Analysis ; False Positive Reactions ; Health Policy ; HIV Infections - prevention & control ; HIV Infections - transmission ; Humans ; Nucleic Acid Amplification Techniques ; Risk Assessment ; Tissue and Organ Procurement ; Tissue Donors - supply & distribution ; United States</subject><ispartof>Progress in transplantation (Aliso Viejo, Calif.), 2011-09, Vol.21 (3), p.236-247</ispartof><rights>2011 NATCO: The Organization for Transplant Professionals</rights><rights>Copyright North American Transplant Coordinators Organization Sep 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</citedby><cites>FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21977885$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shafer, Teresa J.</creatorcontrib><creatorcontrib>Schkade, David</creatorcontrib><creatorcontrib>Schkade, Lawrence</creatorcontrib><creatorcontrib>Geier, Steven S.</creatorcontrib><creatorcontrib>Orlowski, Jeffrey P.</creatorcontrib><creatorcontrib>Klintmalm, Goran</creatorcontrib><title>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</title><title>Progress in transplantation (Aliso Viejo, Calif.)</title><addtitle>Prog Transplant</addtitle><description>Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted.</description><subject>AIDS Serodiagnosis</subject><subject>Cost-Benefit Analysis</subject><subject>False Positive Reactions</subject><subject>Health Policy</subject><subject>HIV Infections - prevention & control</subject><subject>HIV Infections - transmission</subject><subject>Humans</subject><subject>Nucleic Acid Amplification Techniques</subject><subject>Risk Assessment</subject><subject>Tissue and Organ Procurement</subject><subject>Tissue Donors - supply & distribution</subject><subject>United States</subject><issn>1526-9248</issn><issn>2164-6708</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp9kctuEzEUhi0EomngBVhUFhtWQ308nozdXZXSixRRhAILNiPbY0duZ-xgj5H6DH3pOk0BqUgsjqwjf-c_lx-hd0A-ArTtMTR0ISjjAIQCITURL9CMwoJVi5bwl2i2A6odcYAOU7ohhLaMk9fogIJoW86bGbr_YWLAX126xeswmCi9NngZ0pTwyv0y6QSvQko4WLwuf2k7SD9JNRh8HTclx2fZ4CngyzxKj6_GMfvQG-u0M17f4e8u5oQ_Zz0Yp_Gpdj1emzQ5v9kpfgmT8ZOTAz4LPsT0Br2yckjm7dM7R9_OP62Xl9Xq-uJqebqqNAUmKkZkw2rCSM1ZTcsqqoQlFlplOeubRiumGhCNlr0FDgp6wjSntaqVEhbqOfqw193G8DOXebrRJW2GspsJOXVcLDgVvDSYo_fPyJuQoy_DFejxmFQUiO4hHcuporHdNrpRxrsOSLczqvvXqFJ09KSc1Wj6PyW_nSnA8R5IcmP-tv2P5APqApqa</recordid><startdate>201109</startdate><enddate>201109</enddate><creator>Shafer, Teresa J.</creator><creator>Schkade, David</creator><creator>Schkade, Lawrence</creator><creator>Geier, Steven S.</creator><creator>Orlowski, Jeffrey P.</creator><creator>Klintmalm, Goran</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>201109</creationdate><title>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</title><author>Shafer, Teresa J. ; Schkade, David ; Schkade, Lawrence ; Geier, Steven S. ; Orlowski, Jeffrey P. ; Klintmalm, Goran</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>AIDS Serodiagnosis</topic><topic>Cost-Benefit Analysis</topic><topic>False Positive Reactions</topic><topic>Health Policy</topic><topic>HIV Infections - prevention & control</topic><topic>HIV Infections - transmission</topic><topic>Humans</topic><topic>Nucleic Acid Amplification Techniques</topic><topic>Risk Assessment</topic><topic>Tissue and Organ Procurement</topic><topic>Tissue Donors - supply & distribution</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shafer, Teresa J.</creatorcontrib><creatorcontrib>Schkade, David</creatorcontrib><creatorcontrib>Schkade, Lawrence</creatorcontrib><creatorcontrib>Geier, Steven S.</creatorcontrib><creatorcontrib>Orlowski, Jeffrey P.</creatorcontrib><creatorcontrib>Klintmalm, Goran</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>Progress in transplantation (Aliso Viejo, Calif.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shafer, Teresa J.</au><au>Schkade, David</au><au>Schkade, Lawrence</au><au>Geier, Steven S.</au><au>Orlowski, Jeffrey P.</au><au>Klintmalm, Goran</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors</atitle><jtitle>Progress in transplantation (Aliso Viejo, Calif.)</jtitle><addtitle>Prog Transplant</addtitle><date>2011-09</date><risdate>2011</risdate><volume>21</volume><issue>3</issue><spage>236</spage><epage>247</epage><pages>236-247</pages><issn>1526-9248</issn><eissn>2164-6708</eissn><coden>PTRRBT</coden><abstract>Patients' deaths due to the organ donor shortage make it imperative that every suitable organ be transplanted. False-positive results of tests for infection with the human immunodeficiency virus (HIV) result in lost organs. A survey of US organ procurement organizations collected the numbers of donors and ruled-out potential donors who had a positive result on an HIV test from January 1, 2006, to October 31, 2008. Sixty-two percent of US organ procurement organizations participated. Of the 12397 donor/nondonor cases, 56 (0.45%) had an initial positive result on an HIV antibody or HIV nucleic acid test, and only 8 (14.3%) of those were confirmed positive. Of the false-positive results, 50% were from HIV antibody tests and 50% were from HIV nucleic acid tests. Organs are a scarce, finite, and perishable resource. Use of HIV antibody testing has produced a remarkably safe track record of avoiding HIV transmission, with 22 years of nonoccurrence between transmissions. Because false positives occur with any test, including the HIV Ab test, adding nucleic acid testing to the standard donor testing panel doubles the number of false-positive HIV test results and thus the number of medically suitable donors lost. The required HIV antibody test is 99.99% effective in preventing transmission of the HIV virus. Adding the HIV nucleic acid test to routine organ donor screening could result in as many as 761 to 1551 unnecessary deaths of patients between HIV transmission events because medically suitable organs are wasted.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>21977885</pmid><doi>10.1177/152692481102100309</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1526-9248 |
ispartof | Progress in transplantation (Aliso Viejo, Calif.), 2011-09, Vol.21 (3), p.236-247 |
issn | 1526-9248 2164-6708 |
language | eng |
recordid | cdi_proquest_miscellaneous_896829840 |
source | Sage Journals Online |
subjects | AIDS Serodiagnosis Cost-Benefit Analysis False Positive Reactions Health Policy HIV Infections - prevention & control HIV Infections - transmission Humans Nucleic Acid Amplification Techniques Risk Assessment Tissue and Organ Procurement Tissue Donors - supply & distribution United States |
title | Zero Risk Tolerance Costs Lives: Loss of Transplantable Organs Due to Human Immunodeficiency Virus Nucleic Acid Testing of Potential Donors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A24%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zero%20Risk%20Tolerance%20Costs%20Lives:%20Loss%20of%20Transplantable%20Organs%20Due%20to%20Human%20Immunodeficiency%20Virus%20Nucleic%20Acid%20Testing%20of%20Potential%20Donors&rft.jtitle=Progress%20in%20transplantation%20(Aliso%20Viejo,%20Calif.)&rft.au=Shafer,%20Teresa%20J.&rft.date=2011-09&rft.volume=21&rft.issue=3&rft.spage=236&rft.epage=247&rft.pages=236-247&rft.issn=1526-9248&rft.eissn=2164-6708&rft.coden=PTRRBT&rft_id=info:doi/10.1177/152692481102100309&rft_dat=%3Cproquest_cross%3E896829840%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2149-40a54304038432219b219f0f17bf84d55cb4b5195cadf181b1d04c823b3bb9f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=892748029&rft_id=info:pmid/21977885&rft_sage_id=10.1177_152692481102100309&rfr_iscdi=true |